384 related articles for article (PubMed ID: 18487517)
1. Severe ataxia as a complication of human parvovirus B19 acute encephalitis in a child.
Greco F; Barbagallo ML; Chiodo DC; Guglielmino R; Sorge G
J Child Neurol; 2008 Sep; 23(9):1078-80. PubMed ID: 18487517
[TBL] [Abstract][Full Text] [Related]
2. Acute encephalopathy with human parvovirus B19 infection in hereditary spherocytosis.
Oshima K; Kikuchi A; Mochizuki S; Arai T; Oishi T; Hanada R
Pediatr Infect Dis J; 2008 Jul; 27(7):651-2. PubMed ID: 18520445
[TBL] [Abstract][Full Text] [Related]
3. A child with human parvovirus B19 infection induced aplastic anemia and acute hepatitis: effectiveness of immunosuppressive therapy.
Al-Abdwani RM; Khamis FA; Balkhair A; Sacharia M; Wali YA
Pediatr Hematol Oncol; 2008 Sep; 25(7):699-703. PubMed ID: 18850484
[TBL] [Abstract][Full Text] [Related]
4. Severe parvovirus B19 encephalitis after renal transplantation.
Laurenz M; Winkelmann B; Roigas J; Zimmering M; Querfeld U; Müller D
Pediatr Transplant; 2006 Dec; 10(8):978-81. PubMed ID: 17096771
[TBL] [Abstract][Full Text] [Related]
5. Acute cerebellar ataxia with human parvovirus B19 infection.
Shimizu Y; Ueno T; Komatsu H; Takada H; Nunoue T
Arch Dis Child; 1999 Jan; 80(1):72-3. PubMed ID: 10325764
[TBL] [Abstract][Full Text] [Related]
6. Refractory status epilepticus owing to human parvovirus B19 encephalitis in a child.
Erol I; Alehan F; Yalçin K
J Child Neurol; 2006 Sep; 21(9):820-2. PubMed ID: 16970896
[TBL] [Abstract][Full Text] [Related]
7. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
[TBL] [Abstract][Full Text] [Related]
8. [Acute polyarthritis during a parvovirus B19 primary infection].
Sane F; Lazrek M; Schanen C; Hober C; Dewilde A; Hober D
Ann Biol Clin (Paris); 2006; 64(5):497-9. PubMed ID: 17040883
[TBL] [Abstract][Full Text] [Related]
9. Unusual localisation of chronic arthropathy in lumbar facet joints after parvovirus B19 infection.
Guillaume MP; Hermanus N; Peretz A
Clin Rheumatol; 2002 Aug; 21(4):306-8. PubMed ID: 12189459
[TBL] [Abstract][Full Text] [Related]
10. Renal involvement of human parvovirus B19 in an immunocompetent host.
Taylor G; Drachenberg C; Faris-Young S
Clin Infect Dis; 2001 Jan; 32(1):167-9. PubMed ID: 11106317
[TBL] [Abstract][Full Text] [Related]
11. Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy.
Dennert R; Velthuis S; Westermann D; Donker D; Schalla S; van Suylen RJ; Heymans S
Antivir Ther; 2010; 15(4):681-5. PubMed ID: 20587861
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with high-dose intravenous immunoglobulin for parvovirus b19 infection associated with acute fulminant hepatitis in a chinese child.
Cao YH; Zhang GY; Zhang GC
Clin Pediatr (Phila); 2009 Jul; 48(6):674-6. PubMed ID: 19286620
[No Abstract] [Full Text] [Related]
13. Life threatening parvovirus B19 and herpes simplex virus associated acute myocardial dysfunction in a child with homozygous sickle cell disease.
Krishnamurti L; Lanford L; Munoz R
Pediatr Blood Cancer; 2007 Dec; 49(7):1019-21. PubMed ID: 16700044
[TBL] [Abstract][Full Text] [Related]
14. A possible parvovirus B19 encephalitis in an immunocompetent adult patient.
Tonnellier M; Bessereau J; Carbonnell N; Guidet B; Méritet JF; Kerr JR; Monnier-Cholley L; Offenstadt G; Maury E
J Clin Virol; 2007 Feb; 38(2):186-7. PubMed ID: 17174596
[No Abstract] [Full Text] [Related]
15. Childhood chorea-encephalopathy associated with human parvovirus B19 infection.
Fong CY; de Sousa C
Dev Med Child Neurol; 2006 Jun; 48(6):526-8. PubMed ID: 16700948
[TBL] [Abstract][Full Text] [Related]
16. Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection.
Pistorius LR; Smal J; de Haan TR; Page-Christiaens GC; Verboon-Maciolek M; Oepkes D; de Vries LS
Fetal Diagn Ther; 2008; 24(4):491-4. PubMed ID: 19060481
[TBL] [Abstract][Full Text] [Related]
17. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome.
Kerr JR; Cunniffe VS; Kelleher P; Bernstein RM; Bruce IN
Clin Infect Dis; 2003 May; 36(9):e100-6. PubMed ID: 12715326
[TBL] [Abstract][Full Text] [Related]
18. Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease.
Katragadda L; Shahid Z; Restrepo A; Muzaffar J; Alapat D; Anaissie E
Transpl Infect Dis; 2013 Aug; 15(4):354-60. PubMed ID: 23578205
[TBL] [Abstract][Full Text] [Related]
19. Acute transverse myelitis associated with human parvovirus b19 infection.
Suzuki M; Yoto Y; Ishikawa A; Asakura H; Tsutsumi H
J Child Neurol; 2014 Feb; 29(2):280-2. PubMed ID: 24049056
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
